Abstract
Background: Patients with mood disorder, both unipolar and bipolar, present with significant cognitive dysfunction while unwell and this persists into euthymia. This impairment is to an extent independent of mood symptoms, has significant implications for prognosis, and exerts an effect on overall functioning. Neurobiological data suggest that the cognitive dysfunction may relate to underlying dysfunction of pre-frontal cortical areas of the brain and their connections with limbic structures.
Methods: In this paper we examine the theoretical and neurobiological rationale for psychological treatments which focus on the treatment of cognitive dysfunction. We systematically review preliminary studies using cognitive rehabilitation (CR) based techniques in mood disorders, focussing on clinical contexts in which CR may be particularly likely to be important. In addition we examine important methodological issues in developing such an approach.
Results: There is little evidence of traditional psychotherapies having a beneficial effect on cognitive function. However, there are a small number of studies examining specific CR in major depression and in bipolar disorder. The studies are small and inconclusive. However data on neuropsychological function and neurobiology of major depression suggest that this is an approach which deserves further attention and research.
Conclusion: Further research is required in carefully selected populations, using well defined CR techniques and appropriate comparator treatments. Combination of these techniques with pharmacological and broader psychological treatments is likely to be most effective.
Keywords: Bipolar disorder, clinical trials, cognition, depression, mood disorders, psychological treatment.
CNS & Neurological Disorders - Drug Targets
Title:Psychological Treatments for Cognitive Dysfunction in Major Depressive Disorder: Current Evidence and Perspectives§
Volume: 13 Issue: 10
Author(s): Richard J. Porter, Katie Douglas, Jennifer Jordan, Christopher R. Bowie, Jonathan Roiser and Gin S. Malhi
Affiliation:
Keywords: Bipolar disorder, clinical trials, cognition, depression, mood disorders, psychological treatment.
Abstract: Background: Patients with mood disorder, both unipolar and bipolar, present with significant cognitive dysfunction while unwell and this persists into euthymia. This impairment is to an extent independent of mood symptoms, has significant implications for prognosis, and exerts an effect on overall functioning. Neurobiological data suggest that the cognitive dysfunction may relate to underlying dysfunction of pre-frontal cortical areas of the brain and their connections with limbic structures.
Methods: In this paper we examine the theoretical and neurobiological rationale for psychological treatments which focus on the treatment of cognitive dysfunction. We systematically review preliminary studies using cognitive rehabilitation (CR) based techniques in mood disorders, focussing on clinical contexts in which CR may be particularly likely to be important. In addition we examine important methodological issues in developing such an approach.
Results: There is little evidence of traditional psychotherapies having a beneficial effect on cognitive function. However, there are a small number of studies examining specific CR in major depression and in bipolar disorder. The studies are small and inconclusive. However data on neuropsychological function and neurobiology of major depression suggest that this is an approach which deserves further attention and research.
Conclusion: Further research is required in carefully selected populations, using well defined CR techniques and appropriate comparator treatments. Combination of these techniques with pharmacological and broader psychological treatments is likely to be most effective.
Export Options
About this article
Cite this article as:
Porter J. Richard, Douglas Katie, Jordan Jennifer, Bowie R. Christopher, Roiser Jonathan and Malhi S. Gin, Psychological Treatments for Cognitive Dysfunction in Major Depressive Disorder: Current Evidence and Perspectives§, CNS & Neurological Disorders - Drug Targets 2014; 13 (10) . https://dx.doi.org/10.2174/1871527313666141130223248
DOI https://dx.doi.org/10.2174/1871527313666141130223248 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Malondialdehyde and Superoxide Dismutase in High-dose Calcium Supplemented Women in Relation to Iron and Calcium Panels
Current Nutrition & Food Science Surgical Intervention in Preterm Neonates with Patent Ductus Arteriosus
Current Pediatric Reviews Effects of Thiazolidinediones on Coronary Artery Disease: Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Voltage-Gated Sodium Channels: Mutations, Channelopathies and Targets
Current Medicinal Chemistry Innovative Formulations for the Controlled and Site-specific Delivery of Antiinflammatory Drugs
Current Pharmaceutical Design Assessing Cardiovascular Risk in Patients with Diabetes: An Update
Current Cardiology Reviews Antibiotic Susceptibility Evaluation of Bacterial Agents Causing Infection in Children with Acute Tonsillopharyngitis
Infectious Disorders - Drug Targets The Roles of MicroRNAs in Heart Diseases: A Novel Important Regulator
Current Medicinal Chemistry Rosuvastatin Ameliorates Obesity and Proteinuria in Zucker Diabetic Fatty Rats
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
Current Topics in Medicinal Chemistry Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
Current Alzheimer Research Alterations in Homocysteine Metabolism Among Alcohol Dependent Patients - Clinical, Pathobiochemical and Genetic Aspects
Current Drug Abuse Reviews How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with the Metabolic Syndrome?
Vascular Disease Prevention (Discontinued) Does Data Shape Moral Decision? Or Do Values Shape the Data?
Current Pediatric Reviews Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets
Current Pharmaceutical Design Targeting the Toll-System in Cardiovascular Sciences
Recent Patents on Inflammation & Allergy Drug Discovery 3D Printing as a Significant Achievement for Application in Posttraumatic Surgeries - A Literature Review
Current Medical Imaging Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
Current Cancer Drug Targets Anesthetic-induced Myocardial Conditioning: Molecular Fundamentals and Scope
Current Medicinal Chemistry Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets